A case report on severe nivolumab-induced adverse events similar to primary sclerosing cholangitis refractory to immunosuppressive therapy.
Hirasawa Y, Yoshimura K, Matsui H, Kubota Y, Ishida H, Arai J, Sakaki M, Oguro N, Shida M, Taniguchi M, Hamada K, Ariizumi H, Ishiguro T, Ohkuma R, Sambe T, Horiike A, Imamura CK, Shiozawa E, Wada S, Tsurutani J, Iwamoto S, Uchida N, Kiuchi Y, Tate G, Kobayashi S, Tsunoda T.
Hirasawa Y, et al. Among authors: tate g.
Medicine (Baltimore). 2021 Jun 11;100(23):e25774. doi: 10.1097/MD.0000000000025774.
Medicine (Baltimore). 2021.
PMID: 34114983
Free PMC article.